Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pharmacia, Merck Explain FDA Cmte. Review Of COX-2 Safety To Investors

Feb 19 2001

• By The Pink Sheet

Related Content

COX-2 Class Labeling From Vioxx/Celebrex Data Proposed By FDA Consultant

Feb 19 2001

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window